Physician profile
Noura Semreen
NPI 1417519463
$720.02
in general payments reported to CMS, 2019-2025
9 companies · $720 in 2025
The $720 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $720.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $187.64 | 2025 | Minimed 780g |
| Amgen INC. | $179.14 | 2025 | Tepezza, Evenity, Repatha |
| Corcept Therapeutics | $128.50 | 2025 | Korlym |
| Ascendis Pharma Endocrinology INC | $79.71 | 2025 | Yorvipath |
| Novo Nordisk INC | $36.30 | 2025 | Wegovy, Rybelsus, Ozempic |
| Rhythm Pharmaceuticals, INC. | $31.40 | 2025 | Imcivree |
| Tandem Diabetes Care, INC. | $30.77 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Radius Health, INC. | $29.00 | 2025 | Tymlos |
| Insulet Corporation | $17.56 | 2025 | Omnipod |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noura Semreen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.